Drug Shortage Report for HEPARIN SODIUM INJECTION USP

Last updated on 2020-02-14 History
Report ID 104287
Drug Identification Number 02456958
Brand name HEPARIN SODIUM INJECTION USP
Common or Proper name Heparin Sodium Injection
Company Name STERINOVA INC.
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 5000UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 10
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-01-29
Actual start date
Estimated end date 2020-02-13
Actual end date 2020-02-13
Shortage status Resolved
Updated date 2020-02-14
Company comments Shortage resolved. Product is being distributed to wholesalers on Feb 13th, 2020.
Health Canada comments
Tier 3 Status No
Contact Address 3005 AVENUE JOSE-MARIA ROSELL
SAINT-HYACINTHE, QUEBEC
CANADA J2S 0J9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-02-14 English Compare
v9 2020-02-13 French Compare
v8 2020-02-13 English Compare
v7 2020-02-13 English Compare
v6 2020-02-13 English Compare
v5 2020-02-13 English Compare
v4 2020-01-30 English Compare
v3 2020-01-24 French Compare
v2 2020-01-24 English Compare
v1 2020-01-24 English Compare

Showing 1 to 10 of 10